Mayo Clinic discovers potential cause and treatment for tumo
A team of researchers at Mayo Clinic have identified a possible cause and treatment for inflammatory myofibroblastic tumors, a rare form of sarcoma.

The 12 investigators from Mayo Clinic’s Center for Individualized Medicine, who published their study in Annals of Oncology, have shown that their new treatment may address soft cancer tissue that was previously unresponsive to traditional radiation or chemotherapy.

The study points to a condition called chromoplexy as a factor in tumor growth, and also suggests that ceritinib could be used to treat inflammatory myofibroblastic tumors. These tumors often affect children and young adults, but no standard treatment has yet been developed....